MedKoo Cat#: 530434 | Name: BMS-902483

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BMS-902483 is a potent α7 partial agonist, which improved cognition in preclinical rodent models. BMS-902483 showed FLIR α7 EC50=9.3nM; α7 Electrophysiology, rat; Area EC50 = 140 nM; Peak, Area (Ymax %) = 40, 54. 5-HT3A IC50 = 480 nm. Preclinical and early clinical data suggest that α7 nicotinic acetylcholine receptor (nAChR) agonists have potential for the treatment of cognitive and negative symptoms in schizophrenia patients

Chemical Structure

BMS-902483
CAS# 1192810-88-0

Theoretical Analysis

MedKoo Cat#: 530434

Name: BMS-902483

CAS#: 1192810-88-0

Chemical Formula: C18H20N4O

Exact Mass: 308.1637

Molecular Weight: 308.39

Elemental Analysis: C, 70.11; H, 6.54; N, 18.17; O, 5.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BMS-902483; BMS 902483; BMS902483.
IUPAC/Chemical Name
(1S,2R,4S)-N-(isoquinolin-3-yl)-4'H-4-azaspiro[bicyclo[2.2.2]octane-2,5'-oxazol]-2'-amine
InChi Key
ZDTPXUKLGIDOCS-SFHVURJKSA-N
InChi Code
InChI=1S/C18H20N4O/c1-2-4-14-10-19-16(9-13(14)3-1)21-17-20-11-18(23-17)12-22-7-5-15(18)6-8-22/h1-4,9-10,15H,5-8,11-12H2,(H,19,20,21)/t18-/m0/s1
SMILES Code
[C@@H]1(CC2)[C@@]3(OC(NC4=CC5=C(C=N4)C=CC=C5)=NC3)C[N@]2CC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 308.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Design and Synthesis of a New Series of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship James CookF. Christopher ZusiIvar M. McDonaldDalton KingMatthew D. HillChristiana IwuagwuRobert A. MateHaiquan FangRulin ZhaoBei WangJingfang CutroneBaoqing MaQi GaoRonald J. KnoxMichele MatchettLizbeth GallagherMeredith FerranteDebra Post-MunsonThaddeus MolskiAmy EastonRegina MillerKelli JonesSiva DigavalliFrancine HealyKimberley LentzYulia BenitexWendy ClarkeJoanne NataleJudith A. SiuciakNicholas LodgeRobert ZaczekRex DentonDaniel MorganLinda J. BristowJohn E. MacorRichard E. Olson Publication Date (Web): November 18, 2016 (Article) DOI: 10.1021/acs.jmedchem.6b01506